Knockdown of HACE1 via si-HACE1 decreased ROS and MDA levels (Figure 3A) (p < 0.05) but increased SOD, GSH, and GSH-PX levels (p < 0.05) in the in vitro heart failure model (Figure 3B–3F). Here, HACE1 is linked to heart failure.